Annual report pursuant to Section 13 and 15(d)

NOTE 2: BASIS OF PRESENTATION

v3.19.1
NOTE 2: BASIS OF PRESENTATION
12 Months Ended
Dec. 31, 2018
Notes  
NOTE 2: BASIS OF PRESENTATION

NOTE 2: BASIS OF PRESENTATION

 

The consolidated financial statements of AXIM Biotechnologies, Inc. (formerly Axim International, Inc.) as of December 31, 2018, and 2017 have been prepared in accordance with United States generally accepted accounting principles (“US GAAP”).